SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-010763
Filing Date
2023-06-02
Accepted
2023-06-02 16:05:34
Documents
12
Period of Report
2023-06-01
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K acrs-20230601x8k.htm   iXBRL 8-K 59201
  Complete submission text file 0001558370-23-010763.txt   180024

Data Files

Seq Description Document Type Size
2 EX-101.SCH acrs-20230601.xsd EX-101.SCH 3135
3 EX-101.LAB acrs-20230601_lab.xml EX-101.LAB 15916
4 EX-101.PRE acrs-20230601_pre.xml EX-101.PRE 10223
6 EXTRACTED XBRL INSTANCE DOCUMENT acrs-20230601x8k_htm.xml XML 4792
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 23988655
SIC: 2834 Pharmaceutical Preparations